<DOC>
	<DOCNO>NCT02207322</DOCNO>
	<brief_summary>The main purpose study ass whether early integration palliative supportive care service care patient hospitalize hematopoietic stem cell transplantation ( HSCT ) improve patient ' family caregiver ' quality life mood .</brief_summary>
	<brief_title>Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation ( Shield )</brief_title>
	<detailed_description>This research study evaluate impact early involvement supportive care team work transplant oncology team quality life , symptom , mood patient undergoing stem cell transplantation . The purpose research study find whether introduce patient family undergo stem cell transplantation palliative care team specialize symptom management improve physical psychological symptom patient family experience hospitalization stem cell transplantation . The study use series questionnaire measure participant 's caregiver ' quality life , physical symptom , mood . Study questionnaires complete hospital clinic assistance provide need</detailed_description>
	<criteria>Patients Eligibility Criteria : Adult patient ( â‰¥18 year ) hematologic malignancy admit Massachusetts General Hospital HSCT eligible study . Ability speak English able complete questionnaire minimal assistance require interpreter family member . Caregivers Eligibility Criteria : Adult caregiver ( &gt; 18 year ) patient undergo HSCT MGH agree participate study . A relative friend , identify patient either live patient inperson contact least twice per week . Ability read question English willing complete questionnaire assistance interpreter . Patients prior history HSCT . Patients undergo HSCT benign hematologic condition ( myelodysplastic syndrome ( MDS ) consider benign hematologic condition patient MDS eligible study ) Significant uncontrolled psychiatric disorder ( psychotic disorder , bipolar disorder , major depression ) comorbid disease ( dementia , cognitive impairment ) , treat clinician believe prohibits inform consent participation study . Patients enrol supportive care intervention trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hematopoietic stem cell transplantation ( HSCT )</keyword>
	<keyword>autologous stem cell transplant</keyword>
	<keyword>allogeneic stem cell transplant</keyword>
</DOC>